ipharmaservices5 days agoNICE Assessment Outcomes | Untied Kingdom | Drug News | Updates | 2024 | iPharmaCenterJanuary 10, 2024 NICE recommended Alexion's Kanuma for LAL deficiency Sebelipase alfa, marketed as Kanuma by Alexion, holds an indication...
ipharmaservicesApr 13Colorectal cancer | News | Media | UpdatesApril 08, 2024 Krazati plus cetuximab showed improvement in objective response rate in patients with KRASG12C-mutated CRC Mirati...